Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s share price traded up 27.8% during trading on Wednesday . The company traded as high as GBX 23 ($0.29) and last traded at GBX 23 ($0.29). 113,192 shares were traded during mid-day trading, a decline of 65% from the average session volume of 318,884 shares. The stock had previously closed at GBX 18 ($0.22).
Celadon Pharmaceuticals Stock Performance
The company has a current ratio of 1.92, a quick ratio of 6.97 and a debt-to-equity ratio of 194.82. The stock has a market cap of £15.84 million, a price-to-earnings ratio of -287.50 and a beta of -0.26. The stock’s 50 day moving average is GBX 18.36 and its two-hundred day moving average is GBX 27.79.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
See Also
- Five stocks we like better than Celadon Pharmaceuticals
- High Flyers: 3 Natural Gas Stocks for March 2022
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- EV Stocks and How to Profit from Them
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- What is the S&P/TSX Index?
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
